BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16525180)

  • 21. Overcoming therapeutic resistance in malignant gliomas: current practices and future directions.
    Chakravarti A; Palanichamy K
    Cancer Treat Res; 2008; 139():173-89. PubMed ID: 18236717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New place of the chemotherapy in gliomas].
    Chinot O
    Bull Cancer; 2005 Apr; 92(4):343-54. PubMed ID: 15888391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.
    Yaman E; Buyukberber S; Uner A; Coskun U; Akmansu M; Benekli M; Yamac D; Ozturk B; Kaya AO; Yildiz R; Ozkan S; Gunel N
    Onkologie; 2008 Jun; 31(6):309-13. PubMed ID: 18547971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A practical guide for the management of gliomas].
    Stupp R; Pica A; Mirimanoff RO; Michielin O
    Bull Cancer; 2007 Sep; 94(9):817-22. PubMed ID: 17878102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of recidive malignant gliomas with temozolomide].
    Sipos L; Vitanovics D; Afra D
    Orv Hetil; 2002 May; 143(21):1201-4. PubMed ID: 12073541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade glioma mouse models and their applicability for preclinical testing.
    de Vries NA; Beijnen JH; van Tellingen O
    Cancer Treat Rev; 2009 Dec; 35(8):714-23. PubMed ID: 19767151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Image guidance in malignant gliomas: a focused strategy.
    Katsoulakis E; Beal K; Yamada Y
    CNS Oncol; 2012 Nov; 1(2):131-6. PubMed ID: 25057863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell therapies for glioblastoma.
    Terzis AJ; Niclou SP; Rajcevic U; Danzeisen C; Bjerkvig R
    Expert Opin Biol Ther; 2006 Aug; 6(8):739-49. PubMed ID: 16856796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in molecular genetics and treatment of gliomas].
    Hoang-Xuan K; Idbaih A
    Bull Acad Natl Med; 2011 Jan; 195(1):11-20; discussion 20-1. PubMed ID: 22039700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined modality treatment for central nervous system malignancies.
    Robins HI; Peterson CG; Mehta MP
    Semin Oncol; 2003 Aug; 30(4 Suppl 9):11-22. PubMed ID: 12908133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current management of glioblastoma multiforme.
    Grossman SA; Batara JF
    Semin Oncol; 2004 Oct; 31(5):635-44. PubMed ID: 15497116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rare clinical form of glioblastoma multiforme].
    Ejma M; Waliszewska-Prosół M; Hofman A; Bladowska J; Zub LW; Podemski R
    Postepy Hig Med Dosw (Online); 2014 Mar; 68():316-24. PubMed ID: 24864082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy.
    Karschnia P; Le Rhun E; Vogelbaum MA; van den Bent M; Grau SJ; Preusser M; Soffietti R; von Baumgarten L; Westphal M; Weller M; Tonn JC
    Eur J Cancer; 2021 Oct; 156():93-108. PubMed ID: 34425408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy for glioma: Indian perspective.
    Munshi A; Jalali R
    Indian J Cancer; 2009; 46(2):127-31. PubMed ID: 19346646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioblastoma multiforme: State of the art and future therapeutics.
    Wilson TA; Karajannis MA; Harter DH
    Surg Neurol Int; 2014; 5():64. PubMed ID: 24991467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling in malignant astrocytomas: role of neural stem cells and its therapeutic implications.
    Alcantara Llaguno SR; Chen J; Parada LF
    Clin Cancer Res; 2009 Dec; 15(23):7124-9. PubMed ID: 19934302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical development of experimental therapies for malignant glioma.
    Rainov NG; Heidecke V
    Sultan Qaboos Univ Med J; 2011 Feb; 11(1):5-28. PubMed ID: 21509204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Central Nervous System Malignant Melanoma in Children: A Case Series and Review of the Literature.
    Choi DK; Pillay-Smiley N; Marzec S; Wadhwani NR; DiPatri AJ; Tomita T; Lulla RR
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):616-619. PubMed ID: 29401100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.